These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33429771)

  • 21. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
    Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
    Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
    Li Y; Zhang N; Zhang H; Yang Q
    J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of young age in breast cancer.
    Yildirim E; Dalgiç T; Berberoğlu U
    J Surg Oncol; 2000 Aug; 74(4):267-72. PubMed ID: 10962458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort.
    Fadelu T; Damuse R; Lormil J; Pecan E; Dubuisson C; Pierre V; Rebbeck T; Shulman LN
    Oncologist; 2020 Sep; 25(9):e1372-e1381. PubMed ID: 32584461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution.
    Slaoui M; Mouh FZ; Ghanname I; Razine R; El Mzibri M; Amrani M
    PLoS One; 2016; 11(10):e0164841. PubMed ID: 27760178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of anatomic and prognostic stages of breast cancer according to the 8th edition of the TNM staging system - Retrospective analysis based on data from deceased patients once diagnosed with breast cancer].
    Zombori T; Lehóczky L; Cserni B; Nyári T; Cserni G
    Orv Hetil; 2017 Sep; 158(35):1373-1381. PubMed ID: 28847177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy.
    Yoon TI; Hwang UK; Kim ET; Lee S; Sohn G; Ko BS; Lee JW; Son BH; Kim S; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):311-320. PubMed ID: 28601930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients.
    Bae SY; La Choi Y; Kim S; Kim M; Kim J; Jung SP; Choi MY; Lee SK; Kil WH; Lee JE; Nam SJ
    Breast Cancer Res Treat; 2013 Jun; 139(3):741-50. PubMed ID: 23722313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry.
    Kataoka A; Iwamoto T; Tokunaga E; Tomotaki A; Kumamaru H; Miyata H; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Kinoshita T; Nakamura S; Tokuda Y
    Breast Cancer Res Treat; 2016 Nov; 160(1):163-172. PubMed ID: 27647460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in early-stage triple-negative breast cancer: lessons and limits from clinical practice.
    Pistelli M; Pagliacci A; Battelli N; Santinelli A; Biscotti T; Ballatore Z; Berardi R; Cascinu S
    Anticancer Res; 2013 Jun; 33(6):2737-42. PubMed ID: 23749934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
    Deniz M; DeGregorio A; DeGregorio N; Bekes I; Widschwendter P; Schochter F; Ernst K; Scholz C; Bauer EC; Aivazova-Fuchs V; Weissenbacher T; Kost B; Jueckstock J; Andergassen U; Steidl J; Trapp E; Fasching PA; Häberle L; Beckmann MW; Schneeweiss A; Schrader I; Janni W; Rack B; Friedl TW
    Breast; 2019 Apr; 44():81-89. PubMed ID: 30690254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
    Agostinetto E; Giordano L; Torrisi R; De Sanctis R; Masci G; Losurdo A; Zuradelli M; Tinterri C; Gatzemeier W; Testori A; Alloisio M; De Rose F; Fernandes B; Santoro A
    Clin Breast Cancer; 2020 Aug; 20(4):e481-e489. PubMed ID: 32279915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
    Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
    Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
    van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
    Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival.
    Oven Ustaalioglu BB; Balvan O; Bilici A; Develi A; Aliustaoglu M; Vardar FA; Erkol B
    Clin Transl Oncol; 2015 Nov; 17(11):895-902. PubMed ID: 26081286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do young breast cancer patients have worse outcomes?
    Maggard MA; O'Connell JB; Lane KE; Liu JH; Etzioni DA; Ko CY
    J Surg Res; 2003 Jul; 113(1):109-13. PubMed ID: 12943818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors affecting disease-free survival in patients at age 35 or younger with invasive breast cancer.
    Koca B; Kuru B; Karabicak I; Yürüker SS; Ozen N
    Ann Ital Chir; 2014; 85(3):249-53. PubMed ID: 25074433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer.
    Dubsky PC; Gnant MF; Taucher S; Roka S; Kandioler D; Pichler-Gebhard B; Agstner I; Seifert M; Sevelda P; Jakesz R
    Clin Breast Cancer; 2002 Apr; 3(1):65-72. PubMed ID: 12020397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
    Tang LC; Jin X; Yang HY; He M; Chang H; Shao ZM; Di GH
    BMC Cancer; 2015 Mar; 15():201. PubMed ID: 25885213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.